First AD

Second AD

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Neoadjuvant HER2+

The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

Precision Medicine in Oncology®

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Special Reports in Personalized Cancer Care

Post-Conference Perspectives: Optimizing the Management of HER2+ Metastatic Breast Cancer

OncLive News Network®

HER2+ Metastatic Breast Cancer: Standard of Care Therapies

Management of CNS Metastases in R/R HER2+ mBC

HER2+ mBC: Systemic Therapies and HER2CLIMB-02 Trial

Emerging Data for the Treatment of HER2+ mBC

HER2+ Breast Cancer: Brain Metastasis Prevalence & Later-Line Therapy

The HER2CLIMB-02 Trial Design, Results and Implications

HER2CLIMB-02 Trial Regimen Toxicities and Impact

Current Advancements in HER2+ Breast Cancer Management